News | November 16, 2006

Prostate Cancer Patients Report Fewer Side Effects with IMRT than with Brachytherapy

In one of the first studies to compare side effects of IMRT and permanent prostate brachytherapy (I-125) for treatment of low-risk prostate cancer, researchers say patients had fewer moderate and serious side effects when treated with IMRT.
"Both treatments demonstrated excellent PSA outcomes (biochemical control) after treatment," said Thomas N. Eade, MBChB, a fellow in the department of radiation oncology at Fox Chase Cancer Center. "The patients who received IMRT tended to be older, but even with that factor, IMRT was better tolerated."
The study included 374 patients with low-risk prostate cancers treated at Fox Chase with either IMRT (216 patients) or I-125 seed brachytherapy (158 patients). Patients who received neoadjuvant hormones were excluded from the study. The IMRT dose ranged from 74 to 78 Gy. The implant dose was 145 Gy. IMRT patients were an average of three years older (median age 67.6 years compared to 64.7 years).
Serious long-term side effects were significantly higher in the I-125 patients, including urethral stricture (narrowing) and catheterization. Catheterization within the first three months was required in three of the IMRT patients and 11 of the I-125 patients. Only one IMRT patient and seven of the implant patients required catheterization more than three months after completing treatment.
"This study shows men treated with brachytherapy have an increased risk of long-term side effects with brachytherapy as compared to IMRT," Eade said. "Advances in technologies will continue to improve outcomes for both treatment modalities, but for now IMRT delivers excellent cancer control with fewer long-term problems."

Related Content

Ambra Health Launches Mobile App for Instant Medical Image Access
Technology | Mobile Devices | November 09, 2018
Ambra Health announced the launch of its first iOS mobile app for healthcare providers and patient access. Designed...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Carestream Spotlights Healthcare IT and Imaging Systems at RSNA 2018
News | Information Technology | October 31, 2018
Carestream announced it will be displaying several imaging and healthcare information technology (IT) offerings at the...
Agfa Introducing New MUSICA Workstation at RSNA 2018
News | PACS Accessories | October 04, 2018
At the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 26-30 in Chicago, Agfa HealthCare will...
News | PACS Accessories | October 01, 2018
M*Modal announced that several large U.S. health systems have adopted its cloud-based artificial intelligence (AI)...
Intelerad Medical Systems Appoints New President and CEO
News | Enterprise Imaging | September 25, 2018
September 25, 2018 — Intelerad Medical Systems announced that following the retirement of Randall Oka, its board of d
Technology | Electronic Medical Records (EMR) | September 25, 2018
TransformativeMed, a provider of directly embedded, smart clinical workflow solutions for electronic health records (...
Laurel Bridge Enables Healthcare Providers to Manage Image Archive Migrations and Consolidations
News | Enterprise Imaging | September 25, 2018
September 25, 2018 — Laurel Bridge Software announced improvements to their Exodus Migration and Consolidation Contro
LifeImage LITE Application Expands Image Sharing Network to 1,500 Connected Hospitals
News | Enterprise Imaging | September 04, 2018
September 4, 2018 — LifeImage announced that its recently launched application, LITE, has helped to dramatically incr
Greenville Health System Adopts Agfa HealthCare Enterprise Imaging System
News | Enterprise Imaging | August 31, 2018
Agfa HealthCare and Greenville Health System (GHS), South Carolina, announced the successful implementation of a...